亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Traditional Chinese Medicine Phytochemicals: Promising Therapeutic Agents for Acute Kidney Injury

医学 中医药 急性肾损伤 重症监护医学 肾脏疾病 梅德林 肾 内科学 横纹肌溶解症 疾病
作者
Qian Wang,Jun Li,Ling Chen
出处
期刊: 卷期号:12 (4) 被引量:13
标识
DOI:10.1097/imna-d-25-00037
摘要

INTRODUCTION Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid decline in renal function over a short period. AKI is a major global public health challenge due to its high incidence and associated mortality.[1] Its etiological factors include nephrotoxic drugs, sepsis, ischemia-reperfusion (I/R) injury, major surgical procedures, and rhabdomyolysis, all of which can cause acute damage to the renal parenchyma. The pathogenesis of AKI is complex and multifactorial. Currently, the clinical management of AKI primarily involves addressing the underlying causes, providing supportive care, and employing interventions such as blood purification and renal replacement therapy. The current lack of specific pharmacological treatments for AKI underscores the urgent need to identify novel therapeutic agents and molecular targets. For centuries, traditional Chinese medicine (TCM) has been widely used to prevent and treat renal diseases. More recently, phytochemicals derived from TCM herbs have shown promise in various AKI models. TCM involves a multi-faceted approach that includes the utilization of multiple active components, targets, and pathways; as such, it provides benefits in the clinical management of AKI.[2] However, the complexity of many TCM products has led to a poor understanding of their molecular mechanisms and a lack of worldwide acceptance. In this article, we summarize recent evidence of the clinical effectiveness and underlying mechanisms of TCM-based interventions in AKI, providing insights into their potential role in clinical prevention and therapeutic strategies. NOVEL MOLECULAR MECHANISMS UNDERLYING THE DEVELOPMENT OF AKI The onset of AKI is significantly influenced by inflammatory mediators, particularly those produced by damaged renal tissue or activated immune cells. Interleukins (ILs), which are key elements of the cytokine network, play diverse roles in AKI development, including in inflammation, tissue repair, and injury to distant organs. In addition, ILs mitigate AKI by promoting interactions among renal resident cells, immune cells, and fibroblasts.[3] Macrophages contribute to renal inflammation and repair by changing their phenotype and function. They demonstrate a gradual shift to an anti-inflammatory phenotype due to the tissue microenvironment regulating the suppression of glycolysis-related genes and the promotion of oxidative phosphorylation, which is crucial for tissue repair and remodeling.[4] In AKI, renal epithelial cell loss is not always evident; however, cell death often occurs in severe cases. Apoptosis and regulated necrosis are the standard types of regulatory cell death observed in AKI. Apoptosis, a process that does not provoke an immune reaction, may cause the death of renal tubular cells during their development and regeneration. Whereas regulated necrosis, in which the integrity of the plasma membrane is compromised, results in the death of renal cells after AKI. Evidence strongly suggests that forms of regulated necrosis, including ferroptosis, necroptosis, and pyroptosis, are central to the pathophysiology of acute tubular necrosis, glomerular loss, and renal fibrosis.[5] There is also increasing evidence that the gut microbiota influences AKI development, underscoring its significant link to renal physiology and pathophysiology.[6] For example, quantitative disturbances in the intestinal flora have been observed in AKI patients, and orally administering Lactobacillus casei CERELA 431 has been shown to reduce inflammatory factor production in mice with sepsis-induced AKI. Furthermore, bacteria from the Enterobacteriaceae family, including Escherichia coli and Klebsiella oxytoca, have been found to produce D-alanine in the intestines, and oral administration of D-alanine improves kidney damage in mice with I/R-induced AKI (I/R-AKI). In summary, clinical and experimental findings demonstrate that the gut microbiota and its metabolites influence the progression and outcome of AKI [Figure 1]. Figure 1.: Novel molecular mechanisms of acute kidney injury. IL-6, interleukin 6; IL-17, interleukin 17; TNF-α, tumor necrosis factor α; ROS, reactive oxygen species. NATURAL COMPOUNDS FOUND TO BE EFFECTIVE ANTI-AKI AGENTS Pharmacological research has demonstrated that Ligusticum chuanxiong exhibits analgesic effects, promotes the proliferation of vascular endothelial cells, and provides protection against I/R-AKI. It also confers anti-inflammatory and protective benefits for both the cardiovascular and cerebrovascular systems. Tetramethylpyrazine (TMP), the primary alkaloid found in Ligusticum chuanxiong, exerts significant pharmacological effects on the vascular endothelium and circulatory system. It has also been shown to effectively prevent and treat arsenic-induced AKI (A-AKI) by reducing oxidative stress, suppressing inflammation, inhibiting apoptosis in renal tubular epithelial cells, and modulating autophagy. Recent findings suggest that TMP may alleviate A-AKI by resolving the autophagic flux blockade via a Yes1 associated transcriptional regulator (YAP1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-p62-dependent pathway.[7] Isorhamnetin, a naturally occurring flavonol, also exhibits potent anti-inflammatory and antioxidant activities. Wang et al.[8] investigated its therapeutic potential in cisplatin-induced AKI (Cis-AKI) and found that it significantly attenuated apoptosis and inflammatory responses. In addition, a transcriptomic analysis of renal tissues indicated that isorhamnetin may exert renoprotective effects in Cis-AKI by enhancing fatty acid oxidation mediated by peroxisome proliferator activated receptor γ coactivator-1α (PGC-1α).[8] Treatment with isorhamnetin led to marked upregulation of PGC-1α and its downstream targets, perixisome proliferator-activated receptor α (PPARα) and carnitine palmitoyltransferase 1A (CPT1A), and improved lipid clearance and adenosine triphosphate (ATP) production.[8] These results highlight the therapeutic potential of isorhamnetin in mitigating Cis-AKI through PGC-1α-dependent regulation of mitochondrial energy metabolism. Zhang et al.[9] investigated the key redox mechanisms involved in Cis-AKI and developed a tailored photoacoustic imaging probe, AB-DiOH, capable of reversibly responding to hypochlorite (ClO−) and glutathione (GSH). Using this probe, they demonstrated that astragalin could inhibit excessive production of endogenous ClO−, indicating its potential as a therapeutic agent for AKI. The use of AB-DiOH in screening revealed that astragalin may modulate oxidative stress and influence regulated cell death pathways (e.g., ferroptosis and cuproptosis), with elevated GSH levels serving as a key indicator. To investigate the underlying mechanisms, the regulatory proteins associated with these pathways were examined. They found that in ferroptosis, the lipid peroxidation of polyunsaturated fatty acids on the cell membrane is catalyzed and that human glutathione peroxidase 4 (GPX4) plays a critical role in detoxifying lipid peroxides and protecting against oxidative damage. In cuproptosis, regulatory proteins, such as ferredoxin 1 (FDX1), the copper importer recombinant human high affinity copper uptake protein 1 (SLC31A1), and the copper exporter ATP7B, are involved in maintaining copper homeostasis. Astragalin administration resulted in reduced expression of FDX1 and SLC31A1, and a marked increase in ATP7B expression. These findings suggest that the therapeutic effects of astragalin are mediated by its capacity to inhibit oxidative stress, ferroptosis, and cuproptosis. Quercetin, the principal active compound in Abelmoschus manihot, has shown efficacy in treating coronavirus disease 2019 (COVID-19) and in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) N protein-induced AKI in diabetic mice. Recent studies have revealed that the SARS-CoV-2 N protein directly binds to Smad3, activating the Smad3-cyclin-dependent kinase inhibitor 1A (p21) pathway and inducing AKI via G1 cell cycle arrest.[10] Therefore, targeting Smad3 may be a viable strategy for managing COVID-19-associated AKI (C-AKI). Quercetin appears to inhibit the interaction between the SARS-CoV-2 N protein and Smad3, thereby blocking Smad3 signaling and preventing Smad3-mediated cell death through the p16-dependent G1 arrest pathway.[10] In diabetic mice, particularly those that are older and have existing diabetic kidney disease, the SARS-CoV-2 N protein acts as a pathogenic factor, inducing severe AKI via the Smad3-dependent G1 cell cycle arrest pathway. In such mice, quercetin has been found to prevent C-AKI by inhibiting the SARS-CoV-2 N-Smad3-mediated apoptotic signaling pathway. Quercetin has also been identified as a potential anti-SARS-CoV-2 agent. Leonurine hydrochloride (LH), the primary active alkaloid in Leonurus japonicus, has recently been shown to modulate several pathological processes, including oxidative stress, inflammation, fibrosis, apoptosis, and metabolic dysregulation. A recent study investigated the role LH plays in the regulation of ferroptosis in Cis-AKI.[11] Given that the Nrf2 signaling pathway is a key regulator of oxidative stress and lipid peroxidation and is known to exert protective effects in Cis-AKI, it was expected and observed that knocking out Nrf2 exacerbated ferroptosis. This was mediated by increased expression of ferroptosis-related proteins and iron accumulation in vivo, which led to greater kidney injury. The results of in vitro experiments demonstrated that LH activated Nrf2 and reduced iron accumulation, lipid peroxidation, and ferroptosis. However, these protective effects were abolished in Nrf2-silenced cells. LH significantly improved renal function and reduced kidney injury biomarkers in Cis-AKI models. Importantly, LH activated the Nrf2 antioxidant pathway and attenuated both morphological and biochemical markers of ferroptosis in Cis-AKI. These findings suggest that Nrf2 activation confers renal protection, partly by suppressing lipid peroxide-driven ferroptosis, and highlight the therapeutic potential of LH in the treatment of Cis-AKI. CONCLUSION AND PERSPECTIVE AKI has diverse etiological factors, each with distinct pathogenic mechanisms. Early detection and intervention remain the cornerstones of the effective management of AKI, and the importance of early recovery in patients with AKI is well recognized. There are currently no specific pharmacological therapies for AKI, further clinical studies are required to validate potential treatments, and research on the use of TCM-based interventions for the prevention and treatment of AKI remains limited. Nonetheless, emerging evidence indicates that phytochemicals found in TCM products exert beneficial effects through multi-target and multi-pathway mechanisms and thus may offer unique advantages, such as reduced adverse effects and improved survival outcomes. As new research technologies and methodologies are developed and applied, we deepen our understanding of the mechanisms used by these phytochemicals and the pathological mechanisms of AKI. In turn, this will enable the long-term evaluation of their therapeutic efficacy and reinforce the role that TCM compounds play in the prevention and management of AKI.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
等待若魔完成签到,获得积分10
3秒前
研友_VZG7GZ的应助被落润晓采纳,获得10
6秒前
13秒前
俭朴迎荷完成签到,获得积分10
18秒前
落润晓发布了新的文献求助10
18秒前
rongrongrong完成签到,获得积分10
34秒前
37秒前
40秒前
null的应助被科研通管家采纳,获得10
47秒前
null的应助被科研通管家采纳,获得10
47秒前
繁荣的玲完成签到,获得积分10
53秒前
玩命的智宸完成签到,获得积分10
58秒前
斯文败类的应助被落润晓采纳,获得10
1分钟前
水北完成签到,获得积分10
1分钟前
1分钟前
1分钟前
火星上的笑寒完成签到,获得积分10
1分钟前
传奇3的应助被落润晓采纳,获得10
1分钟前
我与我周旋久完成签到 ,获得积分10
1分钟前
1分钟前
传统完成签到,获得积分10
1分钟前
落润晓发布了新的文献求助10
1分钟前
苹果元灵完成签到,获得积分10
1分钟前
长情的小蕾完成签到,获得积分10
1分钟前
1分钟前
李爱国的应助被towind采纳,获得10
1分钟前
yjdong完成签到,获得积分10
2分钟前
2分钟前
2分钟前
nanwang完成签到,获得积分10
2分钟前
2分钟前
落润晓发布了新的文献求助10
2分钟前
2分钟前
哪块小饼干完成签到,获得积分10
2分钟前
dddj完成签到,获得积分10
2分钟前
奔跑的应助被科研通管家采纳,获得10
2分钟前
Owen的应助被科研通管家采纳,获得10
2分钟前
Akim的应助被Angela采纳,获得20
2分钟前
开心的灭龙完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158789
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748389
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551987
邀请新用户注册赠送积分活动 2471354